NovAliX

Contact
novalix.com
+33368330200

NovAliX SAS

BioParc, Boulevard Sebastien Brant
67400 Illkirch-Graffenstaden
France
+33368330200
novalix.com
Contact
Profile News
Contact

About NovAliX

Strasbourg, France based NovAliX Group is focusing on the development of enabling chemistry and biophysical technologies to support the pharmaceutical industry’s outsourcing needs from discovery to manufacturing. With X-ray protein crystallography, supramolecular mass spectrometry and organic chemistry NovAliX offers comprehensive integrated services in small molecule drug discovery. With advanced NMR technologies, NovAliX provides fine characterization of biologics, thorough analysis of APIs and polymorphism studies to support pharmaceutical development and manufacturing teams.

Read more about NovAliX
Facts about NovAliX
  • Focus : Service
  • Industry : Pharma

News about NovAliX

NovAliX

07-Mar-2024 | business & finance

NovAliX and Max Planck join forces to advance Cryo-EM driven drug discovery

Collaboration will make vital process of translating scientific research and academic insights into real therapies more efficient and more effective

Read news
NovAliX

24-Jan-2023 | business & finance

Artificial intelligence to reduce costs and improve efficiency in drug discovery

Chemical.AI and NovAliX reached a milestone in collaboration

Read news
NovAliX

28-Mar-2018 | business & finance

NovAliX enters into cooperation agreement with Max-Planck spin-off

NovAliX, a drug discovery-focused Contract Research Organization (CRO) announces that it has signed a cooperation agreement with German-based ProteoPlex ...

Read news
NovAliX

17-Jan-2013 | research and development

NovAliX enters into fragment-based drug discovery alliance with Kyowa Hakko Kirin

NovAliX SAS announced that it has entered into a fragment-based drug discovery alliance with Kyowa Hakko Kirin Co., Ltd., Japan. Within the alliance, the ...

Read news
NovAliX

23-Oct-2012 | people

NovAliX Names Dr Luc Van Hijfte as CSO Drug Discovery

NovAliX  has announced that it has appointed pharma research executive Dr Luc Van Hijfte as CSO Drug Discovery.Dr. Van Hijfte brings a wealth of experience ...

Read news
NovAliX

16-Jan-2012 | business & finance

NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration with Teijin Pharma

NovAliX SAS announced that it has entered into a multi-target integrated drug discovery collaboration with Teijin Pharma Limited of Tokyo, Japan.Within the ...

Read news
NovAliX

14-Sep-2011 | business & finance

NovAliX to Collaborate with the Fondation Jérôme Lejeune on Down Syndrome (Trisomy 21)

NovAliX announced that it has entered into a multi-year drug research collaboration in the field of trisomy 21 with the Fondation Jérôme Lejeune.NovAliX ...

Read news
NovAliX

31-Aug-2011 | business & finance

NovAliX and Galapagos Collaborate in Osteoarthritis Discovery Research Program

NovAliX announces that it has entered into drug discovery collaboration in the field of osteoarthritis with Galapagos.Under the terms of this agreement ...

Read news
Show more news about NovAliX

Here you will find NovAliX SAS